KPIs & Operating Metrics(New)
Growth Metrics

Aurora Cannabis (ACB) Receivables (2017 - 2025)

Aurora Cannabis has reported Receivables over the past 9 years, most recently at $31.3 million for Q4 2025.

  • Quarterly Receivables fell 6.78% to $31.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.3 million through Dec 2025, down 6.78% year-over-year, with the annual reading at $33.3 million for FY2025, 6.37% down from the prior year.
  • Receivables was $31.3 million for Q4 2025 at Aurora Cannabis, down from $33.6 million in the prior quarter.
  • Over five years, Receivables peaked at $58.2 million in Q1 2021 and troughed at $21.8 million in Q2 2024.
  • The 5-year median for Receivables is $33.1 million (2022), against an average of $34.4 million.
  • Year-over-year, Receivables tumbled 48.49% in 2022 and then surged 45.73% in 2025.
  • A 5-year view of Receivables shows it stood at $39.6 million in 2021, then decreased by 15.89% to $33.3 million in 2022, then dropped by 5.29% to $31.5 million in 2023, then increased by 6.52% to $33.6 million in 2024, then decreased by 6.78% to $31.3 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Receivables are $31.3 million (Q4 2025), $33.6 million (Q3 2025), and $31.8 million (Q2 2025).